Top of page Skip navigation

    Register today...


    Will you be joining us?


    Exhibitor packages available - reserve your space today

Our thanks to the following organisations for supporting this  year's UK Bioscience Forum





Hammersmith Medicines Research (HMR) is a clinical research organisation (CRO) specialising in phase 1 and early phase 2 studies.  We’ve done more than 800 trials – almost all conceivable types, many of them first administration to humans.  We have:  new premises with 145 beds; 240 staff; MHRA GCP and GMP approval; laboratory and pharmacy accreditation; and ISO9001 quality system.

Trio Medicines is a wholly-owned subsidiary of HMR, with a portfolio of three compounds at different stages of development, and a BIA member.



Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. Used by scientists and clinicians around the world, our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, and cell culture.

Our 25 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Today, Miltenyi Biotec has more than 1,400 employees in 25 countries – all dedicated to helping researchers and clinicians make a greater impact on science and health.



Potter Clarkson


Potter Clarkson LLP is an award winning firm top tier of European patent and trade mark attorneys. The firm advises clients worldwide on patents, trademarks, designs and associated aspects of intellectual property.  The 145 strong team includes over 55 patent and trade mark professionals working together at a single site in Nottingham.  Their technical qualifications and experience are outstanding.  Specialist sectors include: Biotechnology and Pharmaceuticals; Chemistry; Designs and Engineering; Electronics and Computing; and Energy and Clean Technologies.



Public Health England (PHE) is a new Executive Agency of the UK Department of Health that is responsible for protecting and improving the nation’s health and wellbeing and reducing inequalities. With ~6000 staff and £1 billion operational budget, we provide a nationwide, integrated public health service supporting people to make healthier choices and providing expertise, information and intelligence. Our translational research, development and testing programmes focus on diagnostics, vaccines and other interventions across healthcare and public health.

Stratagem IPM

Stratagem Intellectual Property Management Ltd is a full-service, Cambridge UK-based, out sourced intellectual organisation and management company with global reach.


Stratagem IPM Ltd fills a developing need within industry for the provision of strategic advice and intellectual property management for life science, medtech, cleantech and high technology companies.  Stratagem’s qualified patent and trade mark attorneys use a commercial perspective and hands on management approach to enhance the value of IP assets.